Literature DB >> 17931297

Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study.

Janaki Amin1, Dianne O'Connell, Mark Bartlett, Elizabeth Tracey, John Kaldor, Matthew Law, Gregory Dore.   

Abstract

BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) incidence has increased in Australia in the past 20-30 years. We conducted a community-based linkage study to examine the characteristics of hepatocellular carcinoma with particular reference to hepatitis B and C infections.
METHODS: Hepatocellular carcinoma cases (n=2,072) notified to the New South Wales (NSW) Central Cancer Registry from 1990 to 2002 were probabilistically linked to HBV and HCV diagnoses notified to NSW Health. Sex, age, year of diagnosis, region of birth, method of diagnosis and spread at diagnosis and survival were compared by linkage group.
RESULTS: Hepatocellular carcinoma incidence increased from 1.4/100,000 in 1990 to 2.8/100,000 in 2002. Incidence varied by region of birth (p<0.001), with people born in Vietnam having the highest relative rate compared with those born in Australia (RR=11.7, 95% CI 9.8-13.8). Of the hepatocellular carcinoma records, 15.6%, 12.9% and 0.8% were linked to hepatitis B, hepatitis C and hepatitis B/C co-infection respectively and 70.7% were unlinked. Median age at diagnosis of HCV-related hepatocellular carcinoma varied markedly at 51, 68 and 71 years for Australian, European, and Asian-born groups, respectively (p<0.0001).
CONCLUSION: Contrasting age distribution of HCV-related HCC by country/region of birth is consistent with divergent patterns of HCV transmission. IMPLICATIONS: These data highlight the increase in HCC in NSW and the divergent populations whose needs in terms of treatment, care and prevention will need to be met.

Entities:  

Mesh:

Year:  2007        PMID: 17931297     DOI: 10.1111/j.1753-6405.2007.00121.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  11 in total

Review 1.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

2.  Clinicopathological determinants of survival after hepatic resection of hepatocellular carcinoma in 97 patients--experience from an Australian hepatobiliary unit.

Authors:  Terence C Chua; Akshat Saxena; Francis Chu; Winston Liauw; Jing Zhao; David L Morris
Journal:  J Gastrointest Surg       Date:  2010-06-29       Impact factor: 3.452

Review 3.  Molecular mechanisms underlying occult hepatitis B virus infection.

Authors:  Jasmine Samal; Manish Kandpal; Perumal Vivekanandan
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

4.  Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: effects on health services utilisation.

Authors:  Monica C Robotin; Melanie Q Kansil; Jacob George; Kirsten Howard; Steven Tipper; Miriam Levy; Nghi Phung; Andrew G Penman
Journal:  BMC Health Serv Res       Date:  2010-07-21       Impact factor: 2.655

5.  Cost of treating chronic hepatitis B: comparison of current treatment guidelines.

Authors:  Monica Robotin; Yumi Patton; Melanie Kansil; Andrew Penman; Jacob George
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

Review 6.  Epidemiology and natural history of HCV infection.

Authors:  Behzad Hajarizadeh; Jason Grebely; Gregory J Dore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-02       Impact factor: 46.802

7.  Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study.

Authors:  Heather F Gidding; Gregory J Dore; Janaki Amin; Matthew G Law
Journal:  BMC Public Health       Date:  2011-01-24       Impact factor: 3.295

8.  Cancers in Australia in 2010 attributable to infectious agents.

Authors:  Annika Antonsson; Louise F Wilson; Bradley J Kendall; Christopher J Bain; David C Whiteman; Rachel E Neale
Journal:  Aust N Z J Public Health       Date:  2015-10       Impact factor: 2.939

9.  A record-linkage study of the development of hepatocellular carcinoma in persons with hepatitis C infection in Scotland.

Authors:  S A McDonald; S J Hutchinson; S M Bird; C Robertson; P R Mills; J F Dillon; D J Goldberg
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

Review 10.  Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region.

Authors:  Ran Xu Zhu; Wai-Kay Seto; Ching-Lung Lai; Man-Fung Yuen
Journal:  Gut Liver       Date:  2016-05-23       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.